These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 18473770)

  • 1. New insights into inflammatory bowel disease pathophysiology: paving the way for novel therapeutic targets.
    Stefanelli T; Malesci A; Repici A; Vetrano S; Danese S
    Curr Drug Targets; 2008 May; 9(5):413-8. PubMed ID: 18473770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease.
    Liu Y; Wang X; Hu CA
    Nutrients; 2017 Aug; 9(9):. PubMed ID: 28832517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory Bowel Disease Drugs: A Focus on Autophagy.
    Hooper KM; Barlow PG; Stevens C; Henderson P
    J Crohns Colitis; 2017 Jan; 11(1):118-127. PubMed ID: 27381462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etiopathogenesis of inflammatory bowel diseases.
    Danese S; Fiocchi C
    World J Gastroenterol; 2006 Aug; 12(30):4807-12. PubMed ID: 16937461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of Drug Repurposing Approach for Therapeutic Intervention of Inflammatory Bowel Disease.
    Bhat MA; Usman I; Dhaneshwar S
    Curr Rev Clin Exp Pharmacol; 2024; 19(3):234-249. PubMed ID: 37859409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etiology and pathogenesis of inflammatory bowel disease.
    Schmidt C; Stallmach A
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurologic manifestations in inflammatory bowel diseases: current knowledge and novel insights.
    Zois CD; Katsanos KH; Kosmidou M; Tsianos EV
    J Crohns Colitis; 2010 Jun; 4(2):115-24. PubMed ID: 21122494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory Bowel Disease: Pathophysiology and Current Therapeutic Approaches.
    Abraham BP; Ahmed T; Ali T
    Handb Exp Pharmacol; 2017; 239():115-146. PubMed ID: 28233184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies.
    Ahluwalia B; Moraes L; Magnusson MK; Öhman L
    Scand J Gastroenterol; 2018 Apr; 53(4):379-389. PubMed ID: 29523023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in inflammatory bowel diseases in children.
    Michail S; Ramsy M; Soliman E
    Minerva Pediatr; 2012 Jun; 64(3):257-70. PubMed ID: 22555319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity?
    Bates J; Diehl L
    J Pathol; 2014 Jan; 232(2):112-20. PubMed ID: 24122796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Update on Herbal Products for the Management of Inflammatory Bowel Disease.
    Arya H; Dass R; Chopra B; Kriplani P; Deswal G; Singh Grewal A; Dhingra AK; Kumar S
    Antiinflamm Antiallergy Agents Med Chem; 2023; 22(1):1-9. PubMed ID: 37497699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalizing therapy for inflammatory bowel diseases.
    Ananthakrishnan AN
    Expert Rev Gastroenterol Hepatol; 2013 Aug; 7(6):549-58. PubMed ID: 23985004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New pathophysiological insights and modern treatment of IBD.
    Engel MA; Neurath MF
    J Gastroenterol; 2010 Jun; 45(6):571-83. PubMed ID: 20213337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current therapeutic approaches in inflammatory bowel disease.
    Sohrabpour AA; Malekzadeh R; Keshavarzian A
    Curr Pharm Des; 2010; 16(33):3668-83. PubMed ID: 21128898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of integrin antagonists in the treatment of inflammatory bowel disease.
    Beniwal-Patel P; Saha S
    Expert Opin Biol Ther; 2014 Dec; 14(12):1815-23. PubMed ID: 25288228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets.
    Nanini HF; Bernardazzi C; Castro F; de Souza HSP
    World J Gastroenterol; 2018 Nov; 24(41):4622-4634. PubMed ID: 30416310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current, New and Future Therapeutic Targets in Inflammatory Bowel Disease: A Systematic Review.
    Alimohammadi N; Koosha F; Rafeian-Kopaei M
    Curr Pharm Des; 2020; 26(22):2668-2675. PubMed ID: 32250220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Interplay Between Genetic Risk Factors and Proteolytic Dysregulation in the Pathophysiology of Inflammatory Bowel Disease.
    Solà-Tapias N; Vergnolle N; Denadai-Souza A; Barreau F
    J Crohns Colitis; 2020 Sep; 14(8):1149-1161. PubMed ID: 32090263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory pathways of importance for management of inflammatory bowel disease.
    Pedersen J; Coskun M; Soendergaard C; Salem M; Nielsen OH
    World J Gastroenterol; 2014 Jan; 20(1):64-77. PubMed ID: 24415859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.